2 unknown, 1 active not recruiting. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Active not recruiting 1 |
| Phase 3 | 2 | Unknown 2 |
Follow allo-HSCT: new trials by email Literature Review of allo-HSCT trials Research Report on allo-HSCT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia sonrotoclax, idarubicin/daunorubicin, Cytarabine - Acute Myeloid Leukemia | Phase 2 | Active not recruiting | Shanghai Jiao Tong University School of Medicine | 47 | 2024-10-30 | 2026-04-30 |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL Dexamethasone, vincristine, Cyclophosphamide - Leukemia, Leukemia, Acute | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 80 | 2016-02-14 | 2018-06-21 |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL Chidamide, Dexamethasone, vincristine - Leukemia, Acute, Leukemia, T Cell | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 70 | 2016-02-14 | 2018-06-12 |
Leukemia (2) · Leukemia, T-Cell (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia, Myeloid, Acute (1)
Nanfang Hospital, Southern Medical University (2) · Shanghai Jiao Tong University School of Medicine (1)
China (3)
Hongsheng Zhou, MD, PhD (1) · Junmin Li (1) · Qifa Liu, MD (1)